Mission Bio logo

Mission Bio

The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution.

88 employees · est. 2014 · South San Francisco, United...

VS
Namocell logo

Namocell

The Fastest Way to Single Cells

8 employees · est. 2014 · Mountain View, United States

Mission Bio is the larger of the two.

Side-by-Side Comparison

Mission Bio Namocell
Founded
2014 2014
Headquarters
South San Francisco, United States Mountain View, United States
Employees
88 larger 8
Industry
Biotechnology, Health Care, Clean Energy Biotechnology, Life Sciences
Funding Stage
Growth Series A
Total Funding
$186.50M Not tracked yet
Funding Rounds
14 1
Services
Tapestri Platform, Single-cell Genomic Analysis, Precision Medicine Solutions, CRISPR Genotoxicity Mapping, Multi-omic Data Integration Not tracked yet
Target Customers
Cancer Researchers, Biotechnology Companies, Pharmaceutical Companies, Clinical Researchers, Genomic Scientists Not tracked yet
Taxonomy
Single-cell Targeted DNA Sequencing, Precision Genomics, Droplet Microfluidics, Single-cell Multi-omics Platform, Bioinformatics Support, Oncology Blood Cancers, Solid Tumors, Genome Editing Validation, Precision Medicine, Disease Progression Detection, Treatment Response Analysis, Single-cell Biology, High-throughput Biology, Innovative Biochemistry, Genotype And Phenotype Analysis Single Cell, Cell Sorting, Microfluidics, FACS, Flow Cytometry, Cell Dispensing, Rare Cell Isolation, Single Cell Genomics, Cell Line Development, Cell Line Engineering, Gene Editing, CRISPR & Stem Cell Cloning, Synthetic Biology, Antibody Discovery
Website
missionbio.com namocell.com
Mission Bio logo

About Mission Bio

Mission Bio, founded in 2014, is a key player in the Biotechnology and Health Care industries, with a focus also on Clean Energy. Headquartered in the United States, the company has carved a niche with its Tapestri® Platform, the only technology that delivers single-cell targeted DNA sequencing at s...

Namocell logo

About Namocell

Namocell is a biotechnology startup based in the United States that specializes in providing high-performance single cell sorting and dispensing systems. Founded in 2014, the company's slogan "The Fastest Way to Single Cells" underscores its commitment to enabling single cell research, therapeutics...

We will tell you when either one moves

BounceWatch watches Mission Bio and Namocell for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Mission Bio and Namocell — by email.

Frequently Asked Questions

Mission Bio — The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution.. Namocell — The Fastest Way to Single Cells . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mission Bio has raised $186.50M while Namocell has raised undisclosed funding.
Mission Bio and Namocell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mission Bio with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Mission Bio on 15 Jun 2026, and Namocell on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy